Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel
NASDAQ:MLAB

Mesa Laboratories Q2 2027 Earnings Date & Estimates

Mesa Laboratories logo
$126.16 -1.40 (-1.10%)
Closing price 10/14/2026 04:00 PM Eastern
Extended Trading
$125.50 -0.66 (-0.52%)
As of 04:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mesa Laboratories is estimated to report Q2 2027 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for November 9, 2026 at 4:00 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q2 2027
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
4:00 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Mesa Laboratories in Q2 2027

Mesa Laboratories is expected to post earnings of $2.29 per share on revenue of $62.20 million. Mesa Laboratories has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$2.29
Expected Revenue
$62.20 million

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
$2.68
Last Quarter Revenue
$60.14 million
EPS Beat Rate
5 of last 8 quarters

Prepare for the Q2 2027 Call

Mesa Laboratories Q2 2027 Earnings FAQ

Mesa Laboratories (NASDAQ:MLAB) is estimated to report Q2 2027 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Mesa Laboratories' Q2 2027 earnings conference call is scheduled for Monday, November 9, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Mesa Laboratories to post earnings of $2.29 per share for Q2 2027.

The consensus revenue estimate for Mesa Laboratories is $62.20 million for Q2 2027.

Mesa Laboratories Earnings Headlines

Mesa Laboratories to Lay Off 40 Positions; Targets $9.3 Million Annual Cost Reduction
October 13 at 5:38 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/mesa-laboratories-lay-off-40-125958705.html
Mesa Laboratories To Cut 40 Jobs, Plan $9.3 Mln Cost Savings
October 13 at 12:34 PM  |  rttnews.comhttps://www.rttnews.com/3698543/mesa-laboratories-to-cut-40-jobs-plan-9-3-mln-cost-savings.aspx
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
October 15 at 1:00 AM  |  Porter & Company (Ad)
Mesa Laboratories announces $9.3M cost-savings plan
October 13 at 12:34 PM  |  msn.comhttps://www.msn.com/en-us/news/other/mesa-laboratories-announces-93m-cost-savings-plan/ar-AA2e8YId
Mesa Laboratories Announces Global Restructuring and Cost Savings
October 13 at 8:51 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mesa-laboratories-announces-global-restructuring-and-cost-savings?utm_source=marketbeat.com&utm_medium=referral
Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
October 13 at 8:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/13/3379606/30771/en/mesa-laboratories-announces-restructuring-and-savings-plan-to-reduce-annualized-costs-by-approximately-9-3-million-and-reinvest-approximately-4-3-million-in-profitable-growth.html
See More Mesa Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mesa Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mesa Laboratories and other key companies, straight to your email.

About Mesa Laboratories

Mesa Laboratories (NASDAQ:MLAB) (NASDAQ:MLAB) develops, manufactures and sells products used for quality control, safety monitoring and process validation across healthcare, pharmaceutical, industrial and research markets. The company’s offerings are designed to help customers monitor critical conditions and verify that sterilization, radiation exposure and other controlled processes meet established standards.

Mesa Laboratories’ products include biological and chemical indicators, process challenge devices and related systems for sterilization monitoring. These products are used to assess the effectiveness of sterilization processes in hospitals, laboratories, pharmaceutical manufacturing and other healthcare settings. The company also provides dosimetry products and services that monitor occupational exposure to radiation.

Additional product lines support dialysis and renal-care applications, including testing and monitoring equipment used to evaluate water quality and treatment processes. Mesa Laboratories serves customers in the United States and international markets through direct sales, distributors and specialized industry channels. The company is headquartered in Colorado and has built its business through the development of specialized monitoring technologies and related acquisitions.

View Mesa Laboratories Profile
Earnings Tools